vs
礼蓝动物保健（ELAN）与SILGAN HOLDINGS INC（SLGN）财务数据对比。点击上方公司名可切换其他公司
SILGAN HOLDINGS INC的季度营收约是礼蓝动物保健的1.3倍（$1.5B vs $1.1B），SILGAN HOLDINGS INC净利率更高（1.2% vs -24.1%，领先25.4%），礼蓝动物保健同比增速更快（12.2% vs 4.1%），SILGAN HOLDINGS INC自由现金流更多（$1.2B vs $46.0M），过去两年SILGAN HOLDINGS INC的营收复合增速更高（5.6% vs -2.6%）
礼蓝动物保健是一家美国动物保健制药企业，专注于生产宠物及家畜用药品与疫苗。该公司原为礼来公司旗下子公司，2019年完成分拆独立，目前是全球第三大动物保健企业。
西尔根控股是一家总部位于美国康涅狄格州的消费品包装制造企业，1987年由原大陆制罐公司的两名高管菲尔·西尔弗与格雷格·霍里根共同创立，公司名称正是取自两位创始人的名字组合，目前在全球包装供应链中占据重要市场地位，为众多快消品牌提供各类包装解决方案。
ELAN vs SLGN — 直观对比
营收规模更大
SLGN
是对方的1.3倍
$1.1B
营收增速更快
ELAN
高出8.1%
4.1%
净利率更高
SLGN
高出25.4%
-24.1%
自由现金流更多
SLGN
多$1.2B
$46.0M
两年增速更快
SLGN
近两年复合增速
-2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.5B |
| 净利润 | $-276.0M | $18.2M |
| 毛利率 | 51.5% | 17.2% |
| 营业利润率 | -22.6% | 3.6% |
| 净利率 | -24.1% | 1.2% |
| 营收同比 | 12.2% | 4.1% |
| 净利润同比 | -3350.0% | -59.6% |
| 每股收益（稀释后） | $-0.55 | $0.18 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ELANSLGN
| Q4 25 | $1.1B | $1.5B | ||
| Q3 25 | $1.1B | $2.0B | ||
| Q2 25 | $1.2B | $1.5B | ||
| Q1 25 | $1.2B | $1.5B | ||
| Q4 24 | $1.0B | $1.4B | ||
| Q3 24 | $1.0B | $1.7B | ||
| Q2 24 | $1.2B | $1.4B | ||
| Q1 24 | $1.2B | $1.3B |
净利润ELANSLGN
| Q4 25 | $-276.0M | $18.2M | ||
| Q3 25 | $-34.0M | $113.3M | ||
| Q2 25 | $11.0M | $88.9M | ||
| Q1 25 | $67.0M | $68.0M | ||
| Q4 24 | $-8.0M | $45.1M | ||
| Q3 24 | $364.0M | $100.1M | ||
| Q2 24 | $-50.0M | $76.1M | ||
| Q1 24 | $32.0M | $55.2M |
毛利率ELANSLGN
| Q4 25 | 51.5% | 17.2% | ||
| Q3 25 | 53.4% | 16.3% | ||
| Q2 25 | 57.5% | 19.4% | ||
| Q1 25 | 57.3% | 18.4% | ||
| Q4 24 | 50.9% | 16.9% | ||
| Q3 24 | 52.2% | 16.8% | ||
| Q2 24 | 58.2% | 18.5% | ||
| Q1 24 | 57.3% | 17.0% |
营业利润率ELANSLGN
| Q4 25 | -22.6% | 3.6% | ||
| Q3 25 | -4.4% | 7.4% | ||
| Q2 25 | 2.0% | 7.7% | ||
| Q1 25 | 5.0% | 6.0% | ||
| Q4 24 | -5.0% | 3.4% | ||
| Q3 24 | 54.3% | 7.2% | ||
| Q2 24 | -2.7% | 7.3% | ||
| Q1 24 | 1.0% | 5.5% |
净利率ELANSLGN
| Q4 25 | -24.1% | 1.2% | ||
| Q3 25 | -3.0% | 5.6% | ||
| Q2 25 | 0.9% | 5.8% | ||
| Q1 25 | 5.6% | 4.6% | ||
| Q4 24 | -0.8% | 3.2% | ||
| Q3 24 | 35.3% | 5.7% | ||
| Q2 24 | -4.2% | 5.5% | ||
| Q1 24 | 2.7% | 4.2% |
每股收益（稀释后）ELANSLGN
| Q4 25 | $-0.55 | $0.18 | ||
| Q3 25 | $-0.07 | $1.06 | ||
| Q2 25 | $0.02 | $0.83 | ||
| Q1 25 | $0.13 | $0.63 | ||
| Q4 24 | $-0.01 | $0.42 | ||
| Q3 24 | $0.73 | $0.93 | ||
| Q2 24 | $-0.10 | $0.71 | ||
| Q1 24 | $0.06 | $0.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $545.0M | $1.1B |
| 总债务越低越好 | $3.9B | — |
| 股东权益账面价值 | $6.5B | $2.3B |
| 总资产 | $13.4B | $9.4B |
| 负债/权益比越低杠杆越低 | 0.60× | — |
8季度趋势，按日历期对齐
现金及短期投资ELANSLGN
| Q4 25 | $545.0M | $1.1B | ||
| Q3 25 | $505.0M | $389.2M | ||
| Q2 25 | $539.0M | $317.5M | ||
| Q1 25 | $487.0M | $353.0M | ||
| Q4 24 | $468.0M | $822.9M | ||
| Q3 24 | $490.0M | $368.5M | ||
| Q2 24 | $416.0M | $302.8M | ||
| Q1 24 | $345.0M | $308.6M |
总债务ELANSLGN
| Q4 25 | $3.9B | — | ||
| Q3 25 | $4.0B | — | ||
| Q2 25 | $4.1B | — | ||
| Q1 25 | $4.4B | — | ||
| Q4 24 | $4.3B | — | ||
| Q3 24 | $4.4B | — | ||
| Q2 24 | $5.7B | — | ||
| Q1 24 | $5.8B | — |
股东权益ELANSLGN
| Q4 25 | $6.5B | $2.3B | ||
| Q3 25 | $6.7B | $2.3B | ||
| Q2 25 | $6.8B | $2.2B | ||
| Q1 25 | $6.4B | $2.1B | ||
| Q4 24 | $6.1B | $2.0B | ||
| Q3 24 | $6.5B | $2.1B | ||
| Q2 24 | $5.9B | $1.9B | ||
| Q1 24 | $6.1B | $1.9B |
总资产ELANSLGN
| Q4 25 | $13.4B | $9.4B | ||
| Q3 25 | $13.6B | $9.5B | ||
| Q2 25 | $13.7B | $9.4B | ||
| Q1 25 | $12.9B | $8.8B | ||
| Q4 24 | $12.6B | $8.6B | ||
| Q3 24 | $13.3B | $7.7B | ||
| Q2 24 | $13.8B | $7.7B | ||
| Q1 24 | $14.0B | $7.6B |
负债/权益比ELANSLGN
| Q4 25 | 0.60× | — | ||
| Q3 25 | 0.59× | — | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 0.69× | — | ||
| Q4 24 | 0.70× | — | ||
| Q3 24 | 0.67× | — | ||
| Q2 24 | 0.96× | — | ||
| Q1 24 | 0.95× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $108.0M | $1.3B |
| 自由现金流经营现金流 - 资本支出 | $46.0M | $1.2B |
| 自由现金流率自由现金流/营收 | 4.0% | 83.2% |
| 资本支出强度资本支出/营收 | 5.4% | 4.9% |
| 现金转化率经营现金流/净利润 | — | 71.07× |
| 过去12个月自由现金流最近4个季度 | $284.0M | $422.7M |
8季度趋势，按日历期对齐
经营现金流ELANSLGN
| Q4 25 | $108.0M | $1.3B | ||
| Q3 25 | $219.0M | $340.9M | ||
| Q2 25 | $237.0M | $-221.4M | ||
| Q1 25 | $-4.0M | $-683.4M | ||
| Q4 24 | $177.0M | $935.8M | ||
| Q3 24 | $162.0M | $313.0M | ||
| Q2 24 | $200.0M | $20.9M | ||
| Q1 24 | $2.0M | $-547.8M |
自由现金流ELANSLGN
| Q4 25 | $46.0M | $1.2B | ||
| Q3 25 | $127.0M | $260.8M | ||
| Q2 25 | $180.0M | $-294.2M | ||
| Q1 25 | $-69.0M | $-766.3M | ||
| Q4 24 | $130.0M | $865.0M | ||
| Q3 24 | $120.0M | $252.4M | ||
| Q2 24 | $166.0M | $-35.3M | ||
| Q1 24 | $-22.0M | $-623.1M |
自由现金流率ELANSLGN
| Q4 25 | 4.0% | 83.2% | ||
| Q3 25 | 11.2% | 13.0% | ||
| Q2 25 | 14.5% | -19.1% | ||
| Q1 25 | -5.8% | -52.2% | ||
| Q4 24 | 12.7% | 61.3% | ||
| Q3 24 | 11.7% | 14.5% | ||
| Q2 24 | 14.0% | -2.6% | ||
| Q1 24 | -1.8% | -47.3% |
资本支出强度ELANSLGN
| Q4 25 | 5.4% | 4.9% | ||
| Q3 25 | 8.1% | 4.0% | ||
| Q2 25 | 4.6% | 4.7% | ||
| Q1 25 | 5.4% | 5.7% | ||
| Q4 24 | 4.6% | 5.0% | ||
| Q3 24 | 4.1% | 3.5% | ||
| Q2 24 | 2.9% | 4.1% | ||
| Q1 24 | 2.0% | 5.7% |
现金转化率ELANSLGN
| Q4 25 | — | 71.07× | ||
| Q3 25 | — | 3.01× | ||
| Q2 25 | 21.55× | -2.49× | ||
| Q1 25 | -0.06× | -10.06× | ||
| Q4 24 | — | 20.77× | ||
| Q3 24 | 0.45× | 3.13× | ||
| Q2 24 | — | 0.27× | ||
| Q1 24 | 0.06× | -9.93× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ELAN
| Pet Health | $489.0M | 43% |
| Cattle | $296.0M | 26% |
| Poultry | $237.0M | 21% |
| Swine | $107.0M | 9% |
| Contract Manufacturing | $15.0M | 1% |
SLGN
| Metal Containers | $675.6M | 46% |
| Dispensing And Specialty Closures | $643.6M | 44% |
| Custom Containers | $149.4M | 10% |
